Comparison

Linperlisib (YY-20394)

Item no. V5059-50mg
Manufacturer InvivoChem LLC
CASRN 1702816-75-8
Amount 50 mg
Quantity options 100 mg 10 mg 250 mg 25 mg 500 mg 5 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V5059CAS #:1702816-75-8Purity >=98%

Description: Linperlisib (YY-20394; PI3Kdelta-IN-2)is a novel, potent, orally bioavailable, and highly selective PI3Kdelta inhibitor that was being investigated in a phase I trial for patients with relapse or refractory B-cell malignancies. YY-20394 was developed with specific selectivity against PI3Kdelta and inhibited PI3Kdelta expressing human tumor cells growth both in vitro and in vivo. In addition, YY-20394 significantly inhibited primary tumor growth in immune-competent mice with 4T1 and CT26 tumors, as well as 4T1 lung metastasis with dose dependency. The anti-tumor efficacy of YY-20394 was largely mediated by T cells. More importantly, YY-20394 synergistically enhanced the anti-tumor efficacy of anti-PD-L1 antibody in CT26 model and achieved long-term immune memory which is specific for CT26 tumors, but not for unrelated A20 tumors. In vitro mechanistic studies showed YY-20394 significantly inhibited T cell differentiation into Treg both in mouse splenocyte and in human primary CD4+ T cells, and was especially potent inhibiting their IL-10 secretion in vitro. Analyses of tumors treated with YY-20394 reviewed that YY-20394 decreased the percentage of Treg in the tumor infiltrating leukocytes, as well as IL-10 secretion. It also showed some effects on the myeloid populations in the tumors. These data suggest the YY-20394, a novel PI3Kdelta inhibitor, represents a promising and safe immune modulator and shows great potential as a cancer immuno-therapeutics.

References: https://cancerres.aacrjournals.org/content/77/13_Supplement/5675

YY-20394

Name: YY-20394
CAS#: 1702816-75-8
Chemical Formula: C28H37FN6O5S
Exact Mass: 588.253
Molecular Weight: 588.6994
Elemental Analysis: C, 57.13; H, 6.34; F, 3.23; N, 14.28; O, 13.59; S, 5.45 O
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Technical Information
Synonym: YY-20394; YY 20394; YY20394
Chemical Name: Methanesulfonamide, N-(5-(6-fluoro-8-((4-(1-hydroxy-1-methylethyl)-1-piperidinyl)methyl)-2-(4-morpholinyl)-4-quinazolinyl)-2-methoxy-3-pyridinyl)-
InChi Key: NVWKNQGHVMMAJW-UHFFFAOYSA-N
InChi Code: InChI=1S/C28H37FN6O5S/c1-28(2, 36)20-5-7-34(8-6-20)17-19-13-21(29)15-22-24(31-27(32-25(19)22)35-9-11-40-12-10-35)18-14-23(33-41(4, 37)38)26(39-3)30-16-18/h13-16, 20, 33, 36H, 5-12, 17H2, 1-4H3
SMILES Code: CS(=O)(NC1=CC(C2=C3C=C(F)C=C(CN4CCC(C(C)(O)C)CC4)C3=NC(N5CCOCC5)=N2)=CN=C1OC)=O

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close